The pharmaceutical industry delivered Covid-19 vaccines with unprecedented speed. A rollout of those vaccines could end the public health crisis, and lead to a reopening and rejuvenation of the U.S. economy.
Where do we go from here? What are the next medical breakthroughs that could transform health care and create investment opportunities? Are we prepared for the next public health crisis? And, how will we pay for medical innovation?
Barron’s will host a live Health-Care Investing Roundtable on Feb. 24 to answer these questions, and more.
Our featured speakers are:
Mikael Dolsten, the chief scientist at
(ticker: PFE), which, along with its partner,
(BNTX), developed one of two Covid-19 vaccines approved for use in the U.S.
- Louise Chen, a managing director at Cantor Fitzgerald, and a senior equity research analyst covering pharma and biotech
- Charles Kennedy, MD, a managing partner and CEO of Blue Ox Healthcare Partners, a private-equity firm focused on health-care investing
Barron’s subscribers are invited to join the event, which begins at noon ET. To register, go to events.barrons.com/roundtable.
Email: [email protected]